Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
- 13 March 2008
- Vol. 26 (18), 2191-2202
- https://doi.org/10.1016/j.vaccine.2008.02.048
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- The uncertain burden of Plasmodium falciparum epidemics in AfricaTrends in Parasitology, 2007
- Functional signatures of protective antiviral T‐cell immunity in human virus infectionsImmunological Reviews, 2006
- Potential Impact of Intermittent Preventive Treatment (IPT) on Spread of Drug-Resistant MalariaPLoS Medicine, 2006
- Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic reviewThe Lancet Infectious Diseases, 2005
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Calculation of Liver‐to‐Blood Inocula, Parasite Growth Rates, and Preerythrocytic Vaccine Efficacy, from Serial Quantitative Polymerase Chain Reaction Studies of Volunteers Challenged with Malaria SporozoitesThe Journal of Infectious Diseases, 2005
- Insecticide-treated bed nets and curtains for preventing malariaCochrane Database of Systematic Reviews, 2004
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001
- Anti-HBs Responses to Vaccination with a Human Hepatitis B Vaccine Made by Recombinant DNA Technology in YeastThe Journal of Infectious Diseases, 1986